Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
712
datasets available to search
ShareScore release 0.9.0
Dataset results
712 results for “mantle”
A Study of Rocbrutinib Versus Investigator's Choice of BTK Inhibitors in Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT07377578. IPD Sharing: NO. Countries: 1. Publications: 0.
Biological Insights of First Relapsed-refractory Patients With Mantle Cell Lymphoma: the MANTLE-FIRST BIO Study.
ClinicalTrials.gov study NCT04882475. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Zanubrutinib-rituximab(ZR) in Patients With Newly Diagnosed Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05504603. IPD Sharing: YES. Countries: 1. Publications: 0.
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma
ClinicalTrials.gov study NCT01695941. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib, Obinutuzumab, and Glofitamab for the Treatment of Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06054776. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Non-interventional Study of REVLIMID® (Lenalidomide) Treatment of IPSS Low- or Intermediate-1-risk Myelodysplastic Syndromes Associated With a Deletion 5q or Refractory/Relapsed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04036448. IPD Sharing: YES. Countries: 1. Publications: 0.
Breast Magnetic Resonance Imaging (MRI) Screening After Mantle Radiation Therapy
ClinicalTrials.gov study NCT00925405. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of the Zanubrutinib Given in Combination With Bendamustine and Rituximab in (Elderly or TP53 Alterations or Chemotherapy Intolerance) Patients With Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06136351. IPD Sharing: NO. Countries: 1. Publications: 0.
Combination Therapy With Fludarabine, Mitoxantrone and Rituximab in Mantle Cell Lymphoma
ClinicalTrials.gov study NCT00183989. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Linperlisib Plus Obinutuzumab and Venetoclax for Relapsed and Refractory Blastoid Variant of Mantle Cell Lymphoma.
ClinicalTrials.gov study NCT06324994. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Polatuzumab, Bendamustine and Rituximab in Patients With Relapsed/ Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05868395. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Rocbrutinib in Participants With Relapse or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05716087. IPD Sharing: NO. Countries: 1. Publications: 0.
A Phase 2 Trial of GlOfitamab anD pIrtobrutinib in Mantle Cell Lymphoma Patients With Prior BTK Inhibitor Exposure.
ClinicalTrials.gov study NCT05833763. IPD Sharing: NO. Countries: 1. Publications: 0.
Obinutuzumab, Zanubrutinib, and Lenalidomide Followed Short-Cycle of Obinutuzumab and Cytarabine in Newly Diagnosed Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06504199. IPD Sharing: NO. Countries: 1. Publications: 0.
Interrogating Biological Signaling Pathway Dysregulations and In Vitro Screening With Personalized Therapies in Relapsed or Refractory Mantle Cell Lymphoma, MCL MATCH Trial
ClinicalTrials.gov study NCT04872413. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ultra Low Dose Radiation Delivered Before or After Chemotherapy-Free Targeted Therapy in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT04054167. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Trial of PCI-32765 (BTK Inhibitor) in Combination With Carfilzomib in Relapse/Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT02269085. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Venetoclax and Acalabrutinib in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT03946878. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Acalabrutinib and Rituximab in Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov study NCT05004064. IPD Sharing: NO. Countries: 1. Publications: 0.
Glofitamab With Pirtobrutinib for Relapsed or Refractory Mantle Cell Lymphoma
ClinicalTrials.gov study NCT06252675. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.